Charles River Laboratories CRL Manufacturing — Total Revenue
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's manufacturing — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's manufacturing — total revenue?
- Charles River Laboratories (CRL) reported manufacturing — total revenue of $190.54M in Q1 2026.
- How has Charles River Laboratories's manufacturing — total revenue changed year-over-year?
- Charles River Laboratories's manufacturing — total revenue increased by 6.8% year-over-year, from $178.49M to $190.54M.
- What is the long-term trend for Charles River Laboratories's manufacturing — total revenue?
- Over 2 years (2023 to 2025), Charles River Laboratories's manufacturing — total revenue has grown at a 3.1% compound annual growth rate (CAGR), from $721.44M to $766.41M.
- What does manufacturing — total revenue mean?
- The total amount of money brought in by the manufacturing segment from its business activities.
- How do you interpret manufacturing — total revenue?
- An increase indicates higher market demand or improved pricing power for the segment's products, while a decrease suggests weakening demand or competitive pressure.
- How does manufacturing — total revenue compare across companies?
- Standard revenue metric across all manufacturing-based business segments in the life sciences industry.